한국어
English
日本語
中文(简体)
Dexilant DR Capsule 30 mg (Dexlansoprazole)
22.5mg
Hard capsule · Prescription medication
Takeda Pharmaceutical Co., Ltd.
Dexlansoprazole is an ingredient used to treat peptic ulcers by inhibiting gastric acid secretion.
MFDS ingredient code M255434
Dexlansoprazole belongs to the class of proton pump inhibitors and is used to regulate excessive gastric acid secretion. It is primarily used for the treatment of conditions related to peptic ulcers.
This ingredient reduces gastric acid secretion by blocking the proton pumps in the stomach wall cells. As a result, it helps prevent mucosal damage caused by gastric acid and aids in ulcer healing.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other proton pump inhibitors such as rabeprazole or omeprazole, dexlansoprazole is designed as a dual release formulation, allowing for a longer duration of effect. This enables its effectiveness to be maintained with a once-daily dosage.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
4 total
22.5mg
Hard capsule · Prescription medication
Takeda Pharmaceutical Co., Ltd.
45mg
Hard capsule · Prescription medication
Takeda Pharmaceutical Korea Co., Ltd.
45mg
Hard capsule · Prescription medication
Yuhan Corporation
22.5mg
Prescription medication
Yuhan Corporation
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.